Abstract Number: 532 • 2016 ACR/ARHP Annual Meeting
The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients
Background/Purpose: The DAS28 is a measure of disease activity in rheumatoid arthritis (RA). DAS28 stands for 'disease activity score' and the number 28 refers to…Abstract Number: 912 • 2016 ACR/ARHP Annual Meeting
Urate Lowering Therapy in Moderate to Severe Chronic Kidney Disease
Urate Lowering Therapy in Moderate to Severe Chronic Kidney Disease Levy G, Cheetham C, Shi J, Rashid N Background/Purpose: To determine if urate lowering…Abstract Number: 1945 • 2016 ACR/ARHP Annual Meeting
Development and Validation of Case-Finding Algorithms for the Identification of Patients with ANCA-Associated Vasculitis and Large-Vessel Vasculitis in Healthcare Administrative Databases
Background/Purpose: ANCA-associated vasculitis (AAV) is a group of vasculitides that consists of granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA), and microscopic polyangiitis…Abstract Number: 2358 • 2016 ACR/ARHP Annual Meeting
High-Fat Diet Is Associated with a Higher Incidence of Radiographic Knee OA and Progression of Knee Joint Space Narrowing: Data from the Osteoarthritis Initiative
Background/Purpose: Animal studies have shown that high-fat diet may increase the risk of osteoarthritis (OA), while other evidence suggests that dietary polyunsaturated fatty acids may…Abstract Number: 2470 • 2016 ACR/ARHP Annual Meeting
Treat to Target: Theoretical Agreement Vs Daily Applicability
Background/Purpose: Treat to target (T2T) strategy has been widely recognized as effective and leading to better outcomes. There have been no questions regarding its theoretical…Abstract Number: 149 • 2015 ACR/ARHP Annual Meeting
Characteristics of Patients Diagnosed with Systemic Lupus Erythematosus (SLE) Initiating Treatment with Belimumab in a US Commercially Insured Database: 2010-2014
Background/Purpose: Belimumab, a B-lymphocyte stimulator, was FDA-approved March 2011 for the treatment of adult patients with active, autoantibody-positive SLE receiving standard of care (SOC) medications.…Abstract Number: 828 • 2015 ACR/ARHP Annual Meeting
Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods
Background/Purpose: As there is currently no existing index for quantifying organ damage in systemic sclerosis (SSc), we sought to develop a disease damage index in…Abstract Number: 3173 • 2015 ACR/ARHP Annual Meeting
Premature Mortality Due to Fractures in a Population-Based Prospective Cohort Study of 238,673 Older Women and Men
Background/Purpose: Osteoporotic (OP) fractures and falls are a growing global problem as the population ages. One third of all falls related deaths are attributable to…Abstract Number: 2076 • 2014 ACR/ARHP Annual Meeting
Predictive Modeling of a Fibromyalgia Diagnosis: Increasing the Accuracy Using Real World Data
Background/Purpose: The number of symptoms and comorbidities associated with the chronic pain condition of fibromyalgia (FM) complicates its identification and diagnosis. Methods: This retrospective analysis…Abstract Number: 1882 • 2014 ACR/ARHP Annual Meeting
Examination of Patients Newly Diagnosed with Fibromyalgia: Use of Guideline-Recommended Therapies and Opioids in Clinical Practice
Background/Purpose: Fibromyalgia (FM) affects 2-5% of adults in the United States. Pregabalin (antiepileptic drug [AED]), and duloxetine and milnacipran (serotonin and norepinephrine reuptake inhibitors), are…Abstract Number: 1165 • 2014 ACR/ARHP Annual Meeting
Evaluation of Symptom Control Among Treated Gout Patients in the United States, United Kingdom, and Germany
Background/Purpose: Gout affects approximately 1-4% of the population in developed Western countries. The hallmark signs of gout are elevated serum uric acid (SUA) level, episodes…Abstract Number: 227 • 2014 ACR/ARHP Annual Meeting
Increasing Fat-Mass May Reverse Bone Loss As Detected By DXA Scan
Background/Purpose: Low body mass index (BMI) is a known risk factor for loss of bone mineral density (BMD). It is a part of the FRAX…Abstract Number: 2429 • 2014 ACR/ARHP Annual Meeting
Seasonal Changes May Influence Activity of Rheumatoid Arthritis
Background/Purpose: RA activity during the year was assessed to investigate whether seasonal changes influenced parameters of RA activity. Methods: This study was performed in Fukuoka,…Abstract Number: 2534 • 2013 ACR/ARHP Annual Meeting
Pregnancy Complications In Lupus: Retrospective Observational Analysis From a US Health Claims Database
Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease most frequently affecting women of childbearing age. Women with SLE are known to be at…Abstract Number: 2139 • 2013 ACR/ARHP Annual Meeting
Do Hyaluronic Acid Injections Delay Total Knee Replacement Surgery?
Background/Purpose: More than 27 million adults in the US have knee osteoarthritis (OA), a painful and life-altering disease. Various non-pharmacologic and pharmacologic agents are recommended…